医学
入射(几何)
内科学
抗生素
金黄色葡萄球菌
抗生素耐药性
围手术期
葡萄球菌
关节置换术
关节置换术
抗菌剂
外科
微生物学
生物
细菌
遗传学
光学
物理
作者
Matthew R. Hays,Beau J. Kildow,Curtis W. Hartman,Elizabeth Lyden,Bryan D. Springer,Thomas K. Fehring,Kevin L. Garvin
标识
DOI:10.1016/j.arth.2023.02.025
摘要
BackgroundPeriprosthetic joint infection (PJI) is a devastating complication of knee and hip arthroplasty. Past literature has shown that gram-positive bacteria are commonly responsible for these infections, although limited research exists studying the changes in the microbial profile of PJIs over time. This study sought to analyze the incidence and trends of pathogens responsible for PJI over three decades.MethodsThis is a multi-institutional retrospective review of patients who had a knee or hip PJI from 1990 to 2020. Patients with a known causative organism were included and those with insufficient culture sensitivity data were excluded. There were 731 eligible joint infections from 715 patients identified. Organisms were divided into multiple categories based on genus/species and 5-year increments were used to analyze the study period. The Cochran-Armitage trend tests were used to evaluate linear trends in microbial profile over time and a P-value <.05 was considered statistically significant.ResultsThere was a statistically significant positive linear trend in the incidence of methicillin-resistant Staphylococcus aureus over time (P = .0088) as well as a statistically significant negative linear trend in the incidence of coagulase-negative staphylococci over time (P = .0018). There was no statistical significance between organism and affected joint (knee/hip).ConclusionThe incidence of methicillin-resistant Staphylococcus aureus PJI is increasing over time, whereas, coagulase-negative staphylococci PJI is decreasing, paralleling the global trend of antibiotic resistance. Identifying these trends may help with the prevention and treatment of PJI through methods such as remodeling perioperative protocols, modifying prophylactic/empiric antimicrobial approaches, or transitioning to alternative therapeutic strategies.
科研通智能强力驱动
Strongly Powered by AbleSci AI